menu
    • menu
    [{"orgOrder":0,"company":"National Research Institute for Family Planning, China","sponsor":"Shanghai Jinxiang Latex Products Co.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Acetic Acid","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase II","graph3":"National Research Institute for Family Planning, China","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Vaginal","sponsorNew":"National Research Institute for Family Planning, China \/ Shanghai Jinxiang Latex Products Co.","highestDevelopmentStatusID":"8","companyTruncated":"National Research Institute for Family Planning, China \/ Shanghai Jinxiang Latex Products Co."}]

    Find Clinical Drug Pipeline Developments & Deals for Acetic Acid

    Menu

    Acetic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            National Research Institute for Family Planning, China

                            Country arrow
                            Peptide Process CMC
                            Not Confirmed

                            National Research Institute for Family Planning, China

                            Country arrow
                            Peptide Process CMC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Acetic Acid

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase II

                            Sponsor : Shanghai Jinxiang Latex Products Co.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women.

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            January 12, 2024

                            Lead Product(s) : Acetic Acid

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase II

                            Sponsor : Shanghai Jinxiang Latex Products Co.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth